ABSTRACT
INTRODUCTION: Appendiceal tumors are rare, late-diagnosed neoplasms that may not be differentiated from adnexal masses even by advanced imaging methods and other diagnostic procedures. They may be asymptomatic and remain undiagnosed until surgery. PRESENTATION OF CASE: We report a case of 81-year-old postmenopausal woman presented with abdominal pain. A magnetic resonance imaging revealed right adnexal mass. Laparotomy was performed and detected a 12cm×9cm mucinous tumoral mass arising in the appendix. An appendectomy and a right hemicolectomy with ileo-transverse anastomosis were performed. Histopathological examination was revealed appendiceal mucinous neoplasm with low malignancy potential. DISCUSSION: Gastrointestinal tumors such as appendiceal tumors can mimicking adnexal mass. Therefore, appendiceal tumor kept in mind in a patient with diagnosed adnexal mass, especially patient had non-specific clinical symptoms, laboratory and radiologic findings. CONCLUSION: Gastrointestinal tumors such as appendiceal tumors kept in mind in a patient with diagnosed adnexal mass.
ABSTRACT
BACKGROUND: The objective was to evaluate the learning curve for performing a robotic hysterectomy to treat benign gynaecological disease. METHODS: Thirty-six patients underwent robotic hysterectomy for benign indications. A systematic chart review of consecutive cases was conducted. The collected data included age, BMI, operating time, set-up time, docking time, uterine weight, blood loss, intraoperative complications, postoperative complications, conversions to laparotomy and length of hospital stay. RESULTS: The mean operating, set-up and docking times were 169 ± 54.5, 52.9 ± 12.4 and 7.8 ± 7.6 min, respectively. The learning curve analysis revealed a decrease in both docking and operating times, with both curves plateauing after case 9. CONCLUSIONS: The learning curve analysis revealed a decrease in docking time and operating time after case 9, suggesting that there might be a fast, learning curve for experienced laparoscopic surgeons to master robotic hysterectomy, and that the docking process does not have a significant negative influence on the overall operating time.
Subject(s)
Genital Diseases, Female/surgery , Gynecology/education , Hysterectomy/methods , Learning Curve , Robotic Surgical Procedures , Adult , Body Mass Index , Female , Gynecologic Surgical Procedures/methods , Humans , Intraoperative Complications , Length of Stay , Middle Aged , Multivariate Analysis , Operative Time , Postoperative Complications , Time Factors , Uterus/pathologyABSTRACT
PURPOSE: To investigate the association between C421T polymorphism within exon 4, C575T polymorphism within exon 6 of the RANK gene and bone mineral density (BMD) variations in postmenopausal Turkish women. METHODS: One hundred seventy-eight postmenopausal women (patients = 100 and controls = 78) who applied to Ege University Faculty of Medicine, Department of Physical Medicine and Rehabilitation, for osteoporosis examination were analyzed. BMDs of the lumbar spine and femoral sites were measured. Patient and control groups were established based on their T-score values being above and/or below -1. After venous blood sampling, C421T and C575T polymorphisms of the RANK gene were assessed through PCR process following DNA extraction. RESULTS: Genotype frequencies for the C421T and C575T polymorphisms were compared between the control group and the patient group. No significant difference was detected between the two groups for both polymorphisms. There was also no significant difference between the control and patient groups in terms of the combined genotype (p = 0.752) and the combined haplotype analysis of the C421T and C575T polymorphisms (p = 0.723). In the control and patient groups separately, no significant differences in BMD values either at the femoral sites or at the lumbar spine were detected between the combined genotypes of the two polymorphisms. CONCLUSIONS: The genotypes, combined genotypes and allele frequencies of C421T and C575T polymorphisms of the RANK gene have not been found to be associated with BMD in Turkish women. Further studies including both sexes and more cases are required.
Subject(s)
Bone Density/genetics , Osteoporosis, Postmenopausal/genetics , Polymorphism, Single Nucleotide , Postmenopause/genetics , Receptor Activator of Nuclear Factor-kappa B/genetics , Absorptiometry, Photon , Aged , Case-Control Studies , Female , Genetic Markers , Genotype , Haplotypes , Humans , Linear Models , Logistic Models , Middle Aged , Osteoporosis, Postmenopausal/diagnostic imaging , Polymerase Chain Reaction , Postmenopause/physiology , TurkeyABSTRACT
AIMS: The aims of this study were (1) to investigate the determining risk factors related to early menopause and (2) to compare the relationships between demographic characteristics and hormonal status and leptin levels in subjects with early (no surgical) and natural menopause. STUDY DESIGN: The prospective study was conducted on 500 women with early and 2700 women with natural menopause. Detailed information was collected about their employment status, past and present smoking habits, coffee and alcohol use, educational level and other factors relevant to health. Thirty participants with early menopause and 30 participants with natural menopause were evaluated for hormone and leptin levels. RESULTS: Employment status (OR: 1.94), current smoking (OR: 1.80) and divorced marital status (OR: 1.79) were found to be significant risk factors for early menopause. Mean levels of leptin in natural and early menopause were measured 11.40 ± 4.1 ng/ml and 8.01 ± 3.9 ng/ml, respectively (p = 0001). Leptin levels in the early (r = 0.765, p = 0.001) and natural (r = 0.750, p = 0.001) menopause subjects correlated positively with oestradiol (E2) levels. CONCLUSION: This study shows that early onset of menopause is correlated with smoking, employment status, divorced marital status and lower leptin levels.
Subject(s)
Divorce/statistics & numerical data , Employment/statistics & numerical data , Leptin/blood , Menopause, Premature/ethnology , Smoking/epidemiology , Adult , Blood Pressure , Body Mass Index , Cross-Sectional Studies , Female , Humans , Menopause, Premature/blood , Middle Aged , Prospective Studies , Turkey/epidemiologyABSTRACT
OBJECTIVE: To investigate the effect of exogenous ovarian stimulation with human menopausal gonadotropin (hMG) and recombinant follicle stimulating hormone (rFSH) on the expression of integrins alpha(3), beta(1) in the rat endometrium during implantation. STUDY DESIGN: Following three successive normal estrous cycles the animals were divided into five groups: Group I (n=10, control group) received no medication; Group II (n=10) received 10 units of hMG; Group III (n=10) received 20 units of hMG; Group IV (n=10) received 10 units of rFSH; Group V (n=10) received 20 units of rFSH at midday of middiestrous. The rats were then mated with fertile males. The animals were sacrificed on the day of implantation. The uterine horns were placed in fixative and paraffin blocks of the tissue were cut in 5 microm sections. The tissues were stained with primary antibodies; monoclonal anti-integrin alpha(3) and monoclonal anti-integrin beta(1) using immunohistochemical methods. The staining intensities of alpha(3) and beta(1) integrins were calculated separately for epithelium and stroma in each group. RESULTS: Staining intensities of alpha(3) and beta(1) integrins in both the epithelium and the stroma were significantly lower in the treatment groups than the control group (p<0.05). CONCLUSION: Ovarian stimulation by low and high doses of HMG and rFSH may have an effect on endometrial receptivity, possibly via a decrease in expression of integrins in the endometrium during the implantation period.
Subject(s)
Embryo Implantation/physiology , Endometrium/metabolism , Follicle Stimulating Hormone/pharmacology , Integrin alpha3beta1/biosynthesis , Menotropins/pharmacology , Ovulation Induction/methods , Animals , Endometrium/drug effects , Female , Integrin alpha3/biosynthesis , Integrin alpha3beta1/genetics , Integrin beta1/biosynthesis , Menotropins/administration & dosage , RatsABSTRACT
OBJECTIVES: The aim of this study was to evaluate measures of insulin resistance and platelet function in postmenopausal women with oral or transdermal hormone replacement therapy (HRT). SUBJECTS AND METHODS: Eighty women divided into four groups of 20 each were enrolled in the study. Group 1: postmenopausal hysterectomized women who received only transdermal estradiol (13.9 mg/12.5 cm(2)); group 2: women with intact uterus who were treated with estrogen-progestin combination (HRT); group 3: postmenopausal women who were treated with the selective estrogen receptor modulator tibolone, and group 4: women who were not taking any drugs for HRT were chosen as a control group (group 4). RESULTS: In group 2, homeostasis model assessment of insulin resistance and fasting insulin levels were 2.90 +/- 0.37 and 9.3 +/- 3.0 microU/ml, respectively, prior to administration of HRT. These levels were reduced to 1.91 +/- 0.41 (p = 0.001) and 7.1 +/- 2.7 microU/ml (p = 0.002), respectively, after drug therapy. Mean levels of high-sensitivity C-reactive protein (hsCRP) were decreased with HRT only in group 2 (p = 0.002). No changes for biochemical and hematological parameters were observed in the other groups. Platelet function tests showed no differences after HRT in any group. CONCLUSIONS: Estrogen-progestin combination HRT decreased measures of insulin resistance and hsCRP levels, but had no effect on platelet function tests in postmenopausal women.
Subject(s)
C-Reactive Protein/analysis , Estradiol/metabolism , Estrogen Receptor Modulators/metabolism , Estrogens/metabolism , Fibrinogen/metabolism , Hormone Replacement Therapy , Insulin Resistance/physiology , Norpregnenes/metabolism , Postmenopause , Adult , Analysis of Variance , Body Weights and Measures , Estradiol/administration & dosage , Estrogen Receptor Modulators/administration & dosage , Estrogen Replacement Therapy , Estrogens/administration & dosage , Female , Follow-Up Studies , Homeostasis/physiology , Humans , Hysterectomy , Middle Aged , Norpregnenes/administration & dosage , Platelet Function Tests , Postmenopause/physiology , TurkeyABSTRACT
OBJECTIVES: This study investigated the effects of estrogen-only therapy on lipid profile (through susceptibility of low density lipoproteins to oxidation) and on oxidant-antioxidant parameters in surgical menopausal women. PON genotypes are also evaluated considering that they may be associated with the personal differences observed in antioxidant effects induced by estrogen. METHODS: Thirty women who had undergone hysterectomy+bilateral ovariectomy in the last 3 years, with causes other than malignancy were included and given estrogen-only (Premarin-Wyeth Inc. 0.625 mg/day/6 months, equine conjugated estrogen). Blood samples were collected at baseline, first and sixth month of treatment. Serum (total antioxidant activity-TAO and PON activity), erythrocyte (TBARS and catalase activity), LDL and Cu2+ induced ox-LDL (TBARS and diene levels) samples were evaluated and PON1 192 polymorphisms were determined by PCR amplification & restriction enzyme digestion. RESULTS: At the sixth month, a higher TAO activity (p=0.016) and a lower eTBARS (p=0.028) were detected compared to the basal values. LDL and Cu induced ox-LDL TBARS levels at the sixth month of treatment were significantly (p=0.012 and 0.026, respectively) lower compared to the pretreatment values. Baseline eTBARS (p=0.007), LDL TBARS (p=0.044) and eCAT (p=0.033) activities were significantly higher in homozygote Q allele carriers compared to subjects with R allele. LDL TBARS and Cu2+ induced ox-LDLTBARS of QQ subjects (p=0.018 and 0.050) as well as LDL TBARS of QR subjects (p=0.044) showed a significant decrease with estrogen-only treatment. CONCLUSIONS: Our study drives the attention to PON polymorphism in postmenopausal women who have risk for atherosclerosis. Although our data is limited, this study is the first that focuses on the role of PON genotypes in antiatherosclerotic effects of estrogen-only and provides important points for further studies.
Subject(s)
Antioxidants/metabolism , Aryldialkylphosphatase/genetics , Atherosclerosis/genetics , Cholesterol, LDL/metabolism , Estrogen Replacement Therapy/methods , Estrogens, Conjugated (USP)/administration & dosage , Aryldialkylphosphatase/metabolism , Atherosclerosis/prevention & control , Catalase/blood , Cholesterol, LDL/blood , Erythrocytes/chemistry , Erythrocytes/enzymology , Female , Genotype , Humans , Hysterectomy , Middle Aged , Multivariate Analysis , Ovariectomy , Oxidation-Reduction , Polymerase Chain Reaction , Prospective Studies , Thiobarbituric Acid Reactive Substances/analysisABSTRACT
OBJECTIVES: Leptin has a significant role in body weight regulation and energy balance. We examined the effect of tibolone on the body weight and serum leptin levels in postmenopausal women. STUDY DESIGN: Twenty women (aged 43-60 years) participated in this prospective study. All women in this study protocol received 2.5 mg/day of tibolone. Absolute and body mass index (BMI)-corrected serum leptin concentrations and BMI values were measured at baseline, after 3 months, and after 6 months of the tibolone therapy. RESULTS: Tibolone did not affect absolute and BMI-corrected serum leptin levels, and BMI values during the treatment. A significant linear correlation between BMI values and serum leptin levels was observed (p<0.05, r=0.67). CONCLUSIONS: Tibolone seems not to affect serum leptin levels, body weight and BMI values of postmenopausal women. There is a significant correlation between serum leptin levels and BMI values.
Subject(s)
Body Weight/drug effects , Estrogen Receptor Modulators/pharmacology , Leptin/blood , Norpregnenes/pharmacology , Postmenopause/drug effects , Adult , Female , Humans , Middle Aged , Prospective StudiesABSTRACT
OBJECTIVE: To determine the changes in endometrium and serum leptin levels during the periimplantation period of the ovum in the rat in response to exogenous ovarian stimulation by hMG and recombinant FSH (rFSH). DESIGN: Experimental animal study. SETTING: University hospital. INTERVENTION(S): A total of 100 female rats were stimulated with low and high doses of hMG (groups 1 and 2, respectively) and low and high doses of rFSH (groups 3 and 4, respectively) before mating after the regular cycle was observed. The control group of animals was not injected (group 5). The endometrium of the pregnant rats (n = 53) was analyzed by the morphometric method, and serum samples were obtained for leptin and E2 levels at baseline and on the day of implantation. The mitotic index was determined separately for endometrial surface, glandular epithelium, and endometrial stroma by light microscope. MAIN OUTCOME MEASURE(S): Morphometric analysis of endometrium, mitotic index, and serum leptin and E2 levels RESULT(S): The mean number of corpora lutea was significantly higher in groups 2 and 4. The measurement of mucosal depth was found to be significantly higher in group 4 compared with the control group (0.361 +/- 0.03 vs. 0.289 +/- 0.04). The depth of the endometrial surface epithelium was found to be significantly higher in all study groups (groups 1-4) compared with the control group. The depth of the surface epithelium was found to be significantly lower in group 1 compared with the other study groups (groups 2, 3, and 4). The depth of the surface epithelium was also significantly lower in group 2 compared with group 3 (21.58 +/- 3.56 vs. 28.21 +/- 3.56). Mitotic indices that were determined at the endometrial surface epithelium and stroma were all significantly lower in all study groups (groups 1-4) compared with the control group. There was no significant increase for the baseline leptin levels compared with the levels measured on the day of implantation. CONCLUSION(S): In an animal model, exogenous administration of gonadotropins significantly affects the morphology of the endometrium and the mitotic index in the implantation period of the embryo. These morphological effects become more pronounced as we increase the administered dose of exogenous gonadotropins. However, no differences in leptin levels were observed relative to different gonadotropin type and dose regimens.
Subject(s)
Embryo Implantation/physiology , Endometrium/anatomy & histology , Leptin/blood , Ovulation Induction , Animals , Dose-Response Relationship, Drug , Estradiol/blood , Female , Follicle Stimulating Hormone/administration & dosage , Follicle Stimulating Hormone/pharmacology , Menotropins/administration & dosage , Menotropins/pharmacology , Mitotic Index , Rats , Recombinant Proteins/administration & dosage , Recombinant Proteins/pharmacologyABSTRACT
OBJECTIVE: To evaluate the effects of two barriers, one solution, and two pharmacologic agents, in single or in combined use, for preventing postsurgical adhesion formation in the rat model. DESIGN: A randomized, prospective study to evaluate the ability of leuprolide acetate, oxidized regenerated cellulose, medroxyprogesterone acetate, sodium hyaluronate, sodium hyaluronate/carboxymethyl cellulose, in single or in combined use, for preventing adhesion formation in a rat model. ANIMAL(S): Wistar female rats. SETTING: University animal laboratory. INTERVENTION(S): Intramuscular injection of pharmacologic agents before surgery and intraperitoneal application of barriers and solution at the end of surgery. MAIN OUTCOME MEASURE(S): Two weeks after surgery, a second laparotomy was performed and the extent of adhesion formation was determined. RESULT(S): All the treatment groups had fewer, less severe adhesions when compared with controls. The combination of medroxyprogesterone acetate and oxidized regenerated cellulose did enhance the adhesion-reducing capacity of oxidized regenerated cellulose. The performance of sodium hyaluronate solution for adhesion prevention was statistically significant, when compared with oxidized regenerated cellulose alone, or sodium hyaluronate used with carboxymethyl cellulose film. CONCLUSION(S): Pharmacologic agents, barriers, or solutions result in significant reduction of postsurgical adhesions. The sodium hyaluronate solution alone and medroxyprogesterone acetate treatment alone had the least adhesion prevention scores. However, neither monotherapy nor combined therapy proved to be significantly more beneficial.